Related references
Note: Only part of the references are listed.MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
MicroRNAs in ovarian cancer biology and therapy resistance
Marijn T. M. van Jaarsveld et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Role of microRNA in anticancer drug resistance
Tongsen Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
Ming Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer
Nora Bandi et al.
CANCER RESEARCH (2009)
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Yasunori Fujita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
Role of microRNAs in drug-resistant ovarian cancer cells
Antonio Sorrentino et al.
GYNECOLOGIC ONCOLOGY (2008)
MicroRNA-221/222 Negatively Regulates Estrogen Receptor α and Is Associated with Tamoxifen Resistance in Breast Cancer
Jian-Jun Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Qihong Huang et al.
NATURE CELL BIOLOGY (2008)
Dicer-dependent pathways regulate chondrocyte proliferation and differentiation
Tatsuya Kobayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells
Xu-Bao Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Survival benefits with diverse chemotherapy regimens for ovarian cancer: Meta-analysis of multiple treatments
Maria Kyrgiou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Class III β-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients
G Ferrandina et al.
CLINICAL CANCER RESEARCH (2006)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The transcriptional landscape of the mammalian genome
P Carninci et al.
SCIENCE (2005)
MicroRNAs - Critical regulators of development, cellular physiology and malignancy
JT Mendell
CELL CYCLE (2005)
Biological characterization of ovarian cancer: prognostic and therapeutic implications
F. Legge et al.
ANNALS OF ONCOLOGY (2005)
Role of chemotherapy in the management of epithelial ovarian cancer
NS Reed et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2005)
DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells
A Cuconati et al.
GENES & DEVELOPMENT (2003)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation
EC Lai
NATURE GENETICS (2002)
Share Paper
